[go: up one dir, main page]

GB2370770B - Uses of Streptococcus Vaccines - Google Patents

Uses of Streptococcus Vaccines

Info

Publication number
GB2370770B
GB2370770B GB0100092A GB0100092A GB2370770B GB 2370770 B GB2370770 B GB 2370770B GB 0100092 A GB0100092 A GB 0100092A GB 0100092 A GB0100092 A GB 0100092A GB 2370770 B GB2370770 B GB 2370770B
Authority
GB
United Kingdom
Prior art keywords
streptococcus
vaccines
streptococcus vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0100092A
Other versions
GB0100092D0 (en
GB2370770A (en
Inventor
Simon Connolly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0100092A priority Critical patent/GB2370770B/en
Publication of GB0100092D0 publication Critical patent/GB0100092D0/en
Publication of GB2370770A publication Critical patent/GB2370770A/en
Application granted granted Critical
Publication of GB2370770B publication Critical patent/GB2370770B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB0100092A 2001-01-03 2001-01-03 Uses of Streptococcus Vaccines Expired - Fee Related GB2370770B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0100092A GB2370770B (en) 2001-01-03 2001-01-03 Uses of Streptococcus Vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0100092A GB2370770B (en) 2001-01-03 2001-01-03 Uses of Streptococcus Vaccines

Publications (3)

Publication Number Publication Date
GB0100092D0 GB0100092D0 (en) 2001-02-14
GB2370770A GB2370770A (en) 2002-07-10
GB2370770B true GB2370770B (en) 2005-06-01

Family

ID=9906179

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0100092A Expired - Fee Related GB2370770B (en) 2001-01-03 2001-01-03 Uses of Streptococcus Vaccines

Country Status (1)

Country Link
GB (1) GB2370770B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
PL2598165T3 (en) * 2010-07-26 2018-02-28 Qu Biologics Inc. IMMUNOGENIC ANTI-INFLAMMATORY COMPOSITIONS
RU2724895C2 (en) 2014-05-02 2020-06-26 Кью Байолоджикс Инк. Antimicrobial immunomodulation

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487148A (en) * 1967-04-18 1969-12-30 Us Health Education & Welfare Partially digested m protein vaccine and method of making same
US4349540A (en) * 1973-12-10 1982-09-14 Pierre Fabre S.A. Process for preparing vaccines based on antigenic ribosomal fractions
EP0094575A2 (en) * 1982-05-17 1983-11-23 MCMICHAEL, John Compositions for treatment of disease states involving immunological factors
WO1995005454A1 (en) * 1992-02-22 1995-02-23 Cambridge Bacteriophage Technologies Ltd. Engineered bacteriophages and vaccines containing them
US5624904A (en) * 1993-11-17 1997-04-29 Massachusetts Institute Of Technology Method for treating gram positive septicemia
EP0786518A1 (en) * 1996-01-25 1997-07-30 The Provost Fellows and Scholars of the College of the Holy Undivided Trinity of Queen Elizabeth Near Dublin Streptococcus equi vaccine
US5846547A (en) * 1996-01-22 1998-12-08 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
EP0894500A1 (en) * 1997-07-29 1999-02-03 Akzo Nobel N.V. Streptococcus equi vaccine
WO1999013084A1 (en) * 1997-09-12 1999-03-18 Id Vaccine Group a streptococcal vaccines
WO2000056359A2 (en) * 1999-03-19 2000-09-28 Smithkline Beecham Biologicals S.A. Vaccine against streptococcus pneumoniae
WO2000067784A1 (en) * 1999-05-10 2000-11-16 University Of Maryland, Baltimore Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487148A (en) * 1967-04-18 1969-12-30 Us Health Education & Welfare Partially digested m protein vaccine and method of making same
US4349540A (en) * 1973-12-10 1982-09-14 Pierre Fabre S.A. Process for preparing vaccines based on antigenic ribosomal fractions
EP0094575A2 (en) * 1982-05-17 1983-11-23 MCMICHAEL, John Compositions for treatment of disease states involving immunological factors
WO1995005454A1 (en) * 1992-02-22 1995-02-23 Cambridge Bacteriophage Technologies Ltd. Engineered bacteriophages and vaccines containing them
US5624904A (en) * 1993-11-17 1997-04-29 Massachusetts Institute Of Technology Method for treating gram positive septicemia
US5846547A (en) * 1996-01-22 1998-12-08 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
US6270775B1 (en) * 1996-01-22 2001-08-07 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
EP0786518A1 (en) * 1996-01-25 1997-07-30 The Provost Fellows and Scholars of the College of the Holy Undivided Trinity of Queen Elizabeth Near Dublin Streptococcus equi vaccine
EP0894500A1 (en) * 1997-07-29 1999-02-03 Akzo Nobel N.V. Streptococcus equi vaccine
US6120775A (en) * 1997-07-29 2000-09-19 Akzo Nobel N.V. Streptococcus equi vaccine
WO1999013084A1 (en) * 1997-09-12 1999-03-18 Id Vaccine Group a streptococcal vaccines
WO2000056359A2 (en) * 1999-03-19 2000-09-28 Smithkline Beecham Biologicals S.A. Vaccine against streptococcus pneumoniae
WO2000067784A1 (en) * 1999-05-10 2000-11-16 University Of Maryland, Baltimore Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof

Also Published As

Publication number Publication date
GB0100092D0 (en) 2001-02-14
GB2370770A (en) 2002-07-10

Similar Documents

Publication Publication Date Title
AU2002351623A8 (en) Streptococcus antigens
HUP0401017A3 (en) Combination of probiotics
IL227966A0 (en) Vaccine composition
GB0103170D0 (en) Vaccine composition
GB0103171D0 (en) Vaccine composition
GB0130215D0 (en) Vaccine
AU2002336760A8 (en) Mutable vaccines
HUP0402259A3 (en) Vaccines
GB0407935D0 (en) Vaccine
GB0306611D0 (en) Novel vaccine
HUP0303372A3 (en) Vaccine
GB0121171D0 (en) Vaccine
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB2370770B (en) Uses of Streptococcus Vaccines
GB0105238D0 (en) Vaccines
HU0104370D0 (en) Honeyed schnaps of oerseg
TW567810U (en) Massage pillow
GB0113552D0 (en) Vaccines
GB0106589D0 (en) Vaccine
GB0128312D0 (en) Vaccine
GB0103867D0 (en) Vaccine
GB0124137D0 (en) Vaccine
GB0130823D0 (en) Vaccine
GB0115496D0 (en) Vaccine
GB0107511D0 (en) Novel vaccine

Legal Events

Date Code Title Description
746 Register noted 'licences of right' (sect. 46/1977)

Effective date: 20051107

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20160103